Jcog0404
Web1 set 2024 · JCOG0404 was a randomized phase III trial for patients with clinical T3/T4 colorectal cancer to confirm the non-inferiority of laparoscopic surgery (LAP) to open surgery (OP) for OS. There were 1057 patients (OP; 528, LAP; 529) registered to JCOG0404 from Oct 2004 to Mar 2009, and the primary analysis was conducted in September 2014. Web29 gen 2024 · Eligibility criteria in JCOG0404 included histologically proven colon cancer; T3 or deeper lesion without involvement of other organs; N0-2 and M0. D3 lymph node dissection with or without preserving LCA was identified according to the photographs of the resected field collected for central surgical review in JCOG0404.
Jcog0404
Did you know?
Web4 apr 2024 · The Japan Clinical Oncology Group (JCOG) conducted a randomized controlled trial, JCOG0404, to confirm the non-inferiority of laparoscopic surgery (LAP) to … Web18 giu 2024 · The subgroup analysis of the recent JCOG0404 trial, which evaluated laparoscopic versus open complete mesocolic excision, identified T4 disease to be one of the factors contributing to the poor long-term outcome of laparoscopic surgery for stage II/III colorectal cancer, suggesting the need for careful consideration of whether to perform …
Web8 lug 2005 · INTRODUCTION. The benefits of laparoscopic surgery (LAP) in comparison with open surgery (OPEN) have been suggested with respect to decreased morbidity, decreased pain, faster recovery and shorter hospital stay (1 – 4).However, the long-term survival of LAP for colorectal cancer is still unclear, especially for advanced colorectal … Webdissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial Seigo Kitano, Masafumi Inomata, Junki Mizusawa, Hiroshi Katayama, Masahiko …
Web4 apr 2024 · The Japan Clinical Oncology Group (JCOG) conducted a randomized controlled trial, JCOG0404, to confirm the non-inferiority of laparoscopic surgery (LAP) to … WebKitano, Seigo ; Inomata, Masafumi ; Mizusawa, Junki et al. / Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404) : a phase 3, randomised controlled trial. In: The Lancet Gastroenterology and Hepatology. 2024 ; Vol. 2, No. 4. pp. 261-268.
Web26 feb 2024 · Aim: We investigated the clinical impact of D3 lymph node dissection preserving left colic artery (LCA) compared to D3 without LCA preservation using data …
Web25 giu 2009 · The Clinical Trial Review Committee of the Japan Clinical Oncology Group (JCOG) approved the protocol in September 2004, and the study (JCOG0404) has started in November 2004 to elucidate the optimal treatment for T3 or deeper colorectal cancer. Surgeons at 27 specialized institutions will recruit 1050 patients. kent and medway pcn listWeb12 lug 2024 · JCOG0404 is one of the largest RCTs in the world comparing open colectomy to laparoscopic colectomy for patients with colon cancer. In this trial, the proportion of … kent and medway prescribingkent and medway prehabWebA total of 1057 patients were randomized (OP 528, LAP 529) from October 2004 through March 2009. Conversion to OS was only needed for 29 patients (5.4%) in the LS arm. The low conversion rate indicated a high quality of surgeons in this study group. JCOG0404 and results of other large clinical trials are shown in Table 1. kent and medway partnership trust kmptWebMethods: This analysis included patients from 4 randomized controlled trials (RCTs) conducted by the Japan Clinical Oncology Group (JCOG): JCOG0205, JCOG0404, … kent and medway police and crime panelWeb26 feb 2024 · JCOG0404 was registered with the UMIN Clinical Trials Registry, number C000000105, and ClinicalTrials.gov, number NCT00147134. The details of the … kent and medway primary care networksWeb29 gen 2024 · Methods: The data of JCOG0404 (which is a randomized controlled trial comparing open to laparoscopic surgery for stage II/III colon cancer) were used. … isilimela high school